Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Olivier, Christoph B."" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł :
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
Autorzy :
Olivier CB; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany. Electronic address: Christoph.Olivier@universitaets-herzzentrum.de.
Weik P; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Meyer M; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Weber S; Center for Medical Biometry and Medical Informatics, Medical Center - University of Freiburg, Freiburg, Germany.
Anto-Michel N; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Diehl P; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Zhou Q; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Geisen U; Medical Center-University of Freiburg, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
Bode C; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Moser M; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2016 Feb; Vol. 138, pp. 63-68. Date of Electronic Publication: 2015 Nov 01.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antithrombins/*therapeutic use
Atrial Fibrillation/*drug therapy
Blood Platelets/*drug effects
Dabigatran/*therapeutic use
Platelet Aggregation/*drug effects
Receptors, Thrombin/*metabolism
Rivaroxaban/*therapeutic use
Aged ; Aged, 80 and over ; Antithrombins/pharmacology ; Dabigatran/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Pulmonary Embolism/drug therapy ; Rivaroxaban/pharmacology ; Venous Thrombosis/drug therapy
Czasopismo naukowe
Tytuł :
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting.
Autorzy :
Rilinger J; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Meyer M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Schnabel K; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Weik P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Charlet A; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Esser JS; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Zhou Q; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Bode C; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Moser M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Diehl P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Olivier CB; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany. Christoph.Olivier@universitaets-herzzentrum.de.
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2016 Nov; Vol. 42 (4), pp. 558-65.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Observational Study
MeSH Terms :
Atrial Fibrillation*/blood
Atrial Fibrillation*/therapy
Receptors, Purinergic P2Y12*
Stents*
Thromboembolism*/blood
Thromboembolism*/prevention & control
Blood Platelets/*metabolism
Platelet Activation/*drug effects
Platelet Aggregation Inhibitors/*administration & dosage
Aged ; Aged, 80 and over ; Coronary Vessels ; Drug Therapy, Combination ; Female ; Humans ; Male ; Risk Factors
Czasopismo naukowe
Tytuł :
Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
Autorzy :
Olivier CB; Department of Medicine, Stanford Center for Clinical Research (C.B.O., K.W.M.), Stanford University School of Medicine, CA.; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany (C.B.O.).
Fan J; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Askari M; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Mahaffey KW; Department of Medicine, Stanford Center for Clinical Research (C.B.O., K.W.M.), Stanford University School of Medicine, CA.
Heidenreich PA; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Perino AC; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Leef GC; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Ho PM; Division of Cardiology, Denver VA Medical Center, CO (P.M.H.).
Harrington RA; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Department of Medicine, Center for Digital Health (R.A.H., M.P.T.), Stanford University School of Medicine, CA.
Turakhia MP; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Department of Medicine, Center for Digital Health (R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Pokaż więcej
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2019 Aug; Vol. 12 (8), pp. e007604. Date of Electronic Publication: 2019 Aug 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Coronary Artery Disease/*therapy
Fibrinolytic Agents/*administration & dosage
Healthcare Disparities/*trends
Platelet Aggregation Inhibitors/*administration & dosage
Practice Patterns, Physicians'/*trends
Purinergic P2Y Receptor Antagonists/*administration & dosage
Stroke/*prevention & control
Aged ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Drug Utilization/trends ; Female ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Time Factors ; Treatment Outcome ; United States/epidemiology ; United States Department of Veterans Affairs ; Veterans Health
Czasopismo naukowe
Tytuł :
Anticoagulation and anaemia: old opponents from the era of VKA?
Autorzy :
Bode C; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Olivier CB; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Duerschmied D; Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło :
European heart journal [Eur Heart J] 2019 Dec 07; Vol. 40 (46), pp. 3791-3792.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Anemia*
Atrial Fibrillation*
Anticoagulants ; Cohort Studies ; Humans ; Vitamin K
Opinia redakcyjna
Tytuł :
Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health Administration.
Autorzy :
Leef GC; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Perino AC; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Askari M; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Fan J; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Ho PM; Veterans Affairs Eastern Colorado Health Care System, Denver, CO, USA.; University of Colorado School of Medicine, Denver, CO, USA.
Olivier CB; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Longo L; Department of Veteran Affairs, Pharmacy Benefits Management Services, USA.
Mahaffey KW; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Turakhia MP; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.; Center for Digital Health, Stanford University School of Medicine, Stanford, CA, USA.
Pokaż więcej
Źródło :
Journal of pharmacy practice [J Pharm Pract] 2020 Oct; Vol. 33 (5), pp. 647-653. Date of Electronic Publication: 2019 Feb 21.
Typ publikacji :
Journal Article
MeSH Terms :
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Stroke*/drug therapy
Administration, Oral ; Aged ; Anticoagulants/therapeutic use ; Cohort Studies ; Humans ; Retrospective Studies ; Veterans Health
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies